PMC:7696151 / 21431-21640
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 615 | 154-162 | Species | denotes | patients | Tax:9606 |
| 618 | 187-198 | Species | denotes | chikungunya | Tax:37124 |
| 626 | 74-77 | Chemical | denotes | HCQ | MESH:D006886 |
| 627 | 113-116 | Chemical | denotes | MTX | MESH:D008727 |
| 628 | 121-134 | Chemical | denotes | sulfasalazine | MESH:D012460 |
| 642 | 199-208 | Disease | denotes | arthritis | MESH:D001168 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T21 | 199-208 | Phenotype | denotes | arthritis | http://purl.obolibrary.org/obo/HP_0001369 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T152 | 0-209 | Sentence | denotes | In particular, in a randomized controlled open-label study, the impact of HCQ in monotherapy or association with MTX and sulfasalazine was assessed in 72 patients with chronic persistent chikungunya arthritis. |